After weighing the evidence on the compound's safety, the FDA will decide within months how to regulate legal cannabis and whether that will require new agency rules or new legislation from Congress.
- The U.S. Food and Drug Administration is planning to make recommendations on how to regulate the use of popular cannabis compound CBD in food and supplements, the Wall Street Journal reported on Tuesday, citing agency officials.
After weighing the evidence on the compound's safety, the FDA will decide within months how to regulate legal cannabis and whether that will require new agency rules or new legislation from Congress, according to the report.Cannabis products, excluding Jazz Pharmaceuticals PLC's Epidiolex, are illegal at the federal level in the United States, although some states allow their use.
The agency wants to know if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility, Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, told WSJ. When asked for comment, the FDA referred Reuters to a statement from last year which said the agency was taking steps to improve regulatory pathways for the lawful marketing of appropriate cannabis and cannabis-derived products.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
WSJ News Exclusive | FDA, Concerned About Safety, Explores Regulating CBD in Foods, SupplementsThe agency is studying whether cannabis-derived ingredients are safe in food and supplements and aims to reveal its oversight plans in the coming months.
Les mer »
FDA Fast-Tracks Overdose Drug Naloxone for Use Without PrescriptionA pharmaceutical nonprofit was granted priority review from the FDA to make an inexpensive overdose-reversal drug for use without a prescription
Les mer »
Blood pressure tablets recalled over potential cancer risk, FDA announcesFour lots of the blood pressure medication Quinapril were voluntarily recalled over concerns it could increase the risk of cancer, the Food and Drug Administration said.
Les mer »
WSJ News Exclusive | Laid Off Tech Workers Quickly Find New JobsAbout 79% of workers recently hired after a tech-company layoff or termination landed their new job within three months of starting their search, according to a survey
Les mer »
How can light therapy help with seasonal affective disorder?Light boxes are designed to be safe and effective, but they aren’t approved or regulated by the FDA for SAD treatment, so it’s important to understand your options.
Les mer »
Japanese shares end higher on Wall Street gains, financials weighJapanese shares ended higher on Monday, underpinned by Wall Street's strength in the previous session, with heavyweight technology and energy stocks leading the gains, while a drop in banks and insurers weighed on the market.
Les mer »